Luis Enrique M. A.
- Country
- Spain
- Department
- Infectious Disease Department
Research Overview
- Phase 3 Randomized Open‑Label Study of Switching to Lenacapavir Combined with Teropavimab and Zinlirvimab in Virologically Suppressed Adults with HIV‑1
- Randomized, Active-Controlled Phase 2/3 Study of GS-1720 and GS-4182 Versus Biktarvy in Treatment-Naive HIV-1 Patients
- A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection.
Data & Insights
Has run more than one trial at 52 of 137 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in the development of novel therapeutic approaches for HIV-1 infection, with particular focus on evaluating new oral treatment regimens for treatment-naïve patients.
- Weekly oral medication administration
- Fixed-dose combination therapies
- Treatment-naïve patient care
Their research encompasses comparative studies of innovative HIV treatment formulations against established therapies.
HIV Prevention Research
The investigator conducts significant research in HIV prevention strategies, particularly focusing on pre-exposure prophylaxis (PrEP) interventions for high-risk populations.
- Pre-exposure prophylaxis optimization
- Men who have sex with men (MSM) healthcare
- Transgender women's health
Their work examines daily preventive medication regimens using fixed-dose combination therapies.
Special Populations Focus
The investigator demonstrates particular expertise in addressing HIV management and prevention among specific demographic groups.
- High-risk population healthcare
- Long-term treatment outcomes
- Preventive medicine strategies
Their research emphasizes extended follow-up periods to ensure treatment efficacy and safety.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.